The Hindu Business Line : Novo Nordisk, Aurigene in drug discovery pact

DIABETES care major Novo Nordisk A/S of Denmark and Aurigene Discovery Technologies Ltd of Bangalore have announced a two-year discovery collaboration in metabolic disorders.

The pact covers joint discovery on a target and pre-clinical development of a novel lead series at Aurigene.

The Bangalore company focusses on discovery of small drug molecules jointly with pharma and pharmaceutical biotech companies on a risk-sharing basis. It will also be involved in optimising some of Novo's lead series of compounds on the same target.

The agreement is extendable by a year. The announcement comes less than two months after Novo announced a manufacturing tie-up with Torrent Pharma of Ahmedabad.

Mr Sanjeev Shishoo, MD of Novo Nordisk India Pvt Ltd, said, "This agreement is part of Novo Nordisk's strategy to have a network of alliances in India, like the one with Torrent very recently. We believe we can leverage the talent and skill base available in India for mutual development and growth."

Mr C.S.N. Murthy, COO and Head, Strategic Alliances, Aurigene, said, "Aurigene will bring in further diversity to Novo Nordisk's programme.

Mr John Bondo Hansen, Vice-President, Novo Nordisk A/S, who flew from Denmark for this event, said, "India is getting increasingly noticed globally as a base for R&D and scientific capabilities. Novo Nordisk was one of the early movers to notice this change and it tied up with Dr Reddy's, CDRI and Torrent to gain from the local expertise. This agreement is the recognition of the abundant scientific talent here."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BPL to retain alkaline battery business

Ranbaxy gets USFDA nod for overactive bladder drug

L&T wins ONGC rig restoration project

Danlaw Tech pref offer

If RIL backtracks on pact with NTPC, Govt may review KG Basin pact

Eveready acquires BPL battery biz
Deal worth Rs 67 cr; market share to go up to 56 pc

Mercedes steps on biodiesel

Natco Pharma to invest Rs 50 cr in expansion

Wage pact in Tata Steel

Beeyu forms joint venture with Fern Tea for Sri Lanka foray

Novo Nordisk, Aurigene in drug discovery pact

`Indian firms must compete with MNCs in global market'

The growing interest

Exit scheme for defunct cos evokes good response
More firms make use of the scheme's extension till August

Tata Tea chief hints at change in business profile

UB charts Rs 100-cr expansion plan — Announces 15 pc interim dividend